Related Experiment Videos
Genotype/phenotype correlations in X-linked agammaglobulinemia
Arnon Broides1, Wenjian Yang, Mary Ellen Conley
1Department of Immunology, St. Jude Children's Research Hospital, Memphis, USA.
Clinical Immunology (Orlando, Fla.)
|November 22, 2005
Summary
Specific mutations in Bruton's tyrosine kinase (Btk) influence X-linked agammaglobulinemia (XLA) severity. Certain Btk mutations correlate with later diagnosis and higher B cell percentages and IgM levels.
Area of Science:
- Immunology
- Genetics
Background:
- X-linked agammaglobulinemia (XLA) is a primary immunodeficiency characterized by a severe lack of mature B cells.
- Genotype-phenotype correlations in XLA are not well-established, complicating disease management and prediction.
Purpose of the Study:
- To investigate the influence of specific Bruton's tyrosine kinase (Btk) mutations on XLA disease severity.
- To explore whether polymorphic variants in Tec kinase could compensate for Btk deficiency and affect the clinical phenotype.
Main Methods:
- Analysis of age at diagnosis, peripheral blood B cell percentages, and plasma IgM levels in a large cohort of XLA patients.
- Examination of specific Btk mutations and polymorphic variants in the Tec gene.
Main Results:
- Polymorphic variants in Tec were found to have no correlation with phenotypic markers in XLA patients.
- Specific Btk mutations significantly influenced disease severity.
- Mutations allowing some Btk production (e.g., amino acid substitutions, splice defects at conserved sites) were associated with milder phenotypes.
Conclusions:
- The specific mutation in the Btk gene is a key determinant of disease severity in XLA.
- Milder Btk mutations are linked to later diagnosis, higher B cell counts, and elevated IgM levels, suggesting residual Btk function impacts phenotype.